Tamoxifen and its New Derivatives in Cancer Research

E-ISSN： 2212-3970|6|2|237-245

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.6, Iss.2, 2011-05, pp. : 237-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

By Johnston S. Gumbrell L. Evans T. Coleman R. Smith I. Twelves C. Soukop M. Rea D. Earl H. Howell A. Jones A. Canney P. Powles T. Haynes B. Nutley B. Grimshaw R. Jarman M. Halbert G. Brampton M. Haviland J. Dowsett M. Coombes R.

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 341-348

Springer Publishing Company

Access to resources Recommend Favorite

Bacteriochlorophyll a and Its Derivatives: Chemistry and Perspectives for Cancer Therapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 6, 2008-08 ,pp. : 683-697

Bentham Science Publishers

Access to resources Recommend Favorite

Tamoxifen Therapy for Ovarian Cancer in the Adjuvant and Advanced Settings: Systematic Review of the Literature and Implications for Future Research

By Perez-Gracia J.L. Carrasco E.M.

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 201-209

Elsevier

Access to resources Recommend Favorite

Tamoxifen for breast cancer prevention - Arbiter:

By Pritchard K.I.

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 148-150

Elsevier

Access to resources Recommend Favorite

Tamoxifen for the prevention of breast cancer - Pro:

By Fisher B.

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 142-145

Elsevier

Access to resources Recommend Favorite